The development of siRNA-based asthma therapeutics is currently hampered by a paucity of relevant biomarkers and the need to ascertain tissue-specific gene targeting in the context of active disease. Epithelial STAT6 expression is fundamental to asthma pathogenesis in which inflammatory changes are found throughout the respiratory tract. Therefore, to improve preclinical evaluation, we tested the efficacy of STAT6-targeting siRNA within nasal epithelial cells (NEC's) obtained from asthmatic and non-asthmatic donors. STAT6 expression was invariant in both donor groups and amenable to suppression by siRNA treatment. In addition, STAT6 mRNA was also suppressible by apically delivered siRNA treatment in comparative differentiated nasal epithelial cell-line monolayer cultures. Analysis of donor NEC's showed consistent elevation in CCL26 (eotaxin-3) mRNA within the asthmatic group suggesting potential as a relevant biomarker. Furthermore, targeting of STAT6 with siRNA attenuated IL-13-driven CCL26 expression in these cells, pointing to the utility of this approach in preclinical testing. Finally, siRNA-mediated suppression of STAT6 was independent of donor disease phenotype or epithelial cell differentiation status, signifying therapeutic potential.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823017 | PMC |
| http://dx.doi.org/10.1111/jcmm.12014 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Targeted lipid nanoparticles distributed in hydrogel treat osteoarthritis by modulating cholesterol metabolism and promoting endogenous cartilage regeneration.
J Nanobiotechnology
December 2024
Department of Joint Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, 250021, People's Republic of China.
Osteoarthritis (OA) is the most common disease in aging joints and has characteristics of cartilage destruction and inflammation. It is currently considered a metabolic disease, and the CH25H-CYP7B1-RORα axis of cholesterol metabolism in chondrocytes plays a crucial catabolic regulatory role in its pathogenesis. Targeting of this axis in chondrocytes may provide a therapeutic approach for OA treatment.
View Article and Find Full Text PDFsiRNA-based therapy for overcoming drug resistance in human solid tumours; molecular and immunological approaches.
Hum Immunol
December 2024
Department of Pharmaceutical Chemistry, College of Pharmacy, University of Mosul, Mosul 41001, Iraq.
RNA interference (RNAi) is a primordial biological process that protects against external intrusion. SiRNA has the potential to selectively silence disease-related genes in a sequence-specific way, thus offering a promising therapeutic approach. The efficacy of siRNA-based therapies in cancer treatment has gained significant recognition due to multiple studies demonstrating its ability to effectively suppress cancer cells' growth and multiplication.
View Article and Find Full Text PDFAdvanced siRNA delivery in combating hepatitis B virus: mechanistic insights and recent updates.
J Nanobiotechnology
November 2024
Department of Precision Medicine, School of Medicine, Sungkyunkwan University, Suwon, Gyeonggi, 16419, Republic of Korea.
Hepatitis B virus (HBV) infection is a major health problem, causing thousands of deaths each year worldwide. Although current medications can often inhibit viral replication and reduce the risk of liver carcinoma, several obstacles still hinder their effectiveness. These include viral resistance, prolonged treatment duration, and low efficacy in clearing viral antigens.
View Article and Find Full Text PDFResearch on Function of Ribosomal Protein S6 Kinases, 1α and β, Based on Molecular Cloning and siRNA-Based Interference in Juvenile Blunt Snout Bream ().
Biology (Basel)
October 2024
Tongwei Agricultural Development Co., Ltd., Key Laboratory of Nutrition and Healthy Culture of Aquatic, Livestock and Poultry, Ministry of Agriculture and Rural Affairs, Healthy Aquaculture Key Laboratory of Sichuan Province, Chengdu 610093, China.
Article Synopsis
- The study focused on how two isoforms of ribosomal protein S6 kinase 1 (S6K1α and S6K1β) affect the expression of genes related to glycolysis and gluconeogenesis in juvenile blunt snout bream.
- Researchers cloned and characterized these isoforms, revealing their sequences and significant expression in heart and gonads.
- The use of siRNAs demonstrated that S6K1α primarily regulates gluconeogenesis, while both S6K1α and S6K1β work together to co-regulate glycolysis, highlighting their distinct roles in metabolic processes.
Human glyoxylate metabolism revisited: New insights pointing to multi-organ involvement with implications for siRNA-based therapies in primary hyperoxaluria.
J Inherit Metab Dis
January 2025
Department of Pediatric Nephrology, Emma Children's Hospital, Amsterdam, The Netherlands.
Article Synopsis
- - Glyoxylate, a toxic byproduct of metabolism, is rapidly converted into oxalate, necessitating effective detoxification systems in various cell compartments, with key enzymes AGT and GRHPR involved in this process.
- - Mutations in genes encoding AGT and GRHPR lead to primary hyperoxaluria types 1 and 2, respectively, while a defect in the HOGA1 enzyme is associated with type 3, all resulting in serious kidney issues such as nephrocalcinosis and potential kidney failure.
- - Recent advancements in therapies, particularly RNAi-based treatments (lumasiran and nedosiran), are improving outcomes for primary hyperoxaluria, with nedosiran targeting all
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!